LEIDEN – BIOKÉ announced it has signed a distribution agreement with Applied Cells Inc to distribute the MARS® technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Applied Cells is a leading provider of cell preparation and isolation solutions for tumor biology, cell therapy, and genomics research. Their proprietary innovative MARS platform, short-named after “Multi-physics Automated Reconfigurable Separation”, is ideal for gentle, high-efficiency, high-recovery, automated cell separation and sample preparation. The broad selection of MARS configurations provides flexibility to meet versatile workflows for rare cell analysis, immune cell profiling, and cell therapy, with capabilities including target cell enrichment, cell purification, and cell concentration.

“We are excited by the opportunity to offer the MARS instrument from Applied Cells to our customers, it will allow them to identify rare populations for diagnostic markers and potentially isolate new cellular therapeutics,” says Robert Hovingh, Sales Manager BIOKÉ. “We are very excited about the opportunities this technology will enable for cell therapy, tumor biology and genomics research in the Benelux.”

“Applied Cells is bringing benefit to the customers by enabling successful isolation of target cells from complex blood and tissue samples for broad downstream analysis platforms,” says Janette Phi, CCO of Applied Cells. “We are looking forward to working with the knowledgeable BIOKÉ team to provide this innovative technology to research laboratories in the Benelux.”

About Applied Cells

Applied Cells was founded to create revolutionary cell separation and enrichment products, which can increase cell separation efficiency by fundamentally changing how physics is employed in the process. Applied Cells commits to battles against cancer by providing tools that are not only capable of isolating the rarest cancer cells, but also capable of extracting the highest quality immune cells to achieve better cell therapy outcomes, while for a fraction of current market costs to enable broader access. For additional information, visit appliedcells.com

About BIOKÉ

Founded in 2004, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and high-performance products for genomics, protein analysis and cell biology. In July 2009 Cell Signaling Technology, Inc. (CST) acquired BIOKÉ BV and BIOKÉ became a business unit of Cell Signaling Technology Europe. CST Europe and BIOKÉ hold offices in Leiden, the Netherlands. For additional information please visit the website at bioke.com.

MARS is a registered trademark of Applied Cells.